These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22241017)

  • 1. Visual outcome in Japanese patients with Acanthamoeba keratitis.
    Yamazoe K; Yamamoto Y; Shimazaki-Den S; Shimazaki J
    Eye (Lond); 2012 Apr; 26(4):517-22. PubMed ID: 22241017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
    Robaei D; Carnt N; Minassian DC; Dart JK
    Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
    Tu EY; Joslin CE; Sugar J; Shoff ME; Booton GC
    Ophthalmology; 2008 Nov; 115(11):1998-2003. PubMed ID: 18571729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
    Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
    Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
    Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S
    Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis.
    Carnt N; Robaei D; Watson SL; Minassian DC; Dart JK
    Ophthalmology; 2016 May; 123(5):984-90. PubMed ID: 26952591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in Acanthamoeba keratitis.
    Kaiserman I; Bahar I; McAllum P; Srinivasan S; Elbaz U; Slomovic AR; Rootman DS
    Can J Ophthalmol; 2012 Jun; 47(3):312-7. PubMed ID: 22687314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acanthamoeba keratitis with chlorhexidine.
    Kosrirukvongs P; Wanachiwanawin D; Visvesvara GS
    Ophthalmology; 1999 Apr; 106(4):798-802. PubMed ID: 10201605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis.
    Rahimi F; Hashemian SM; Tafti MF; Mehjerdi MZ; Safizadeh MS; Pour EK; Sefidan BB
    J Ophthalmic Vis Res; 2015; 10(2):106-11. PubMed ID: 26425310
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Papa V; Rama P; Radford C; Minassian DC; Dart JKG
    Br J Ophthalmol; 2020 Apr; 104(4):575-581. PubMed ID: 31401556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
    Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
    Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and prognostic factors in Acanthamoeba keratitis.
    Vilares-Morgado R; Ferreira AM; Marques-Couto P; Madeira C; Moreira R; Torrão L; Neves-Cardoso P; Cunha AM; Rebelo S; Pinheiro-Costa J
    Cont Lens Anterior Eye; 2024 Apr; 47(2):102119. PubMed ID: 38220498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acanthamoeba keratitis: a parasite on the rise.
    Thebpatiphat N; Hammersmith KM; Rocha FN; Rapuano CJ; Ayres BD; Laibson PR; Eagle RC; Cohen EJ
    Cornea; 2007 Jul; 26(6):701-6. PubMed ID: 17592320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK.
    Hassan F; Bhatti A; Desai R; Barua A
    Cont Lens Anterior Eye; 2019 Oct; 42(5):506-511. PubMed ID: 31018907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.
    Musayeva A; Riedl JC; Schuster AK; Wasielica-Poslednik J; Pfeiffer N; Gericke A
    Cornea; 2020 Aug; 39(8):986-990. PubMed ID: 32243421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-Year Review of Acanthamoeba Keratitis Related to Wearing Contact Lenses in Korea.
    Jo YJ; Jang SK; Lee J; Lee JS
    Eye Contact Lens; 2020 Jul; 46(4):223-227. PubMed ID: 32443003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of real-time polymerase chain reaction detection of Acanthamoeba and prognosis determinants of Acanthamoeba keratitis.
    Ikeda Y; Miyazaki D; Yakura K; Kawaguchi A; Ishikura R; Inoue Y; Mito T; Shiraishi A; Ohashi Y; Higaki S; Itahashi M; Fukuda M; Shimomura Y; Yagita K
    Ophthalmology; 2012 Jun; 119(6):1111-9. PubMed ID: 22381810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
    Bang S; Edell E; Eghrari AO; Gottsch JD
    Am J Ophthalmol; 2010 Jan; 149(1):66-9. PubMed ID: 19875089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.